Pain Next Generation Imaging In Urology What 39s New Bladder And Kidney Cancers Prof Dr Karolien Goffin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces presentations featuring the Company's theranostic programs at the 36th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Vienna from 9 - 13 September 2023. Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (ClinicalTrials.gov Identifier: NCT03849118) will be presented in on oral session on Sunday 10 September. In addition, the congress program features the following Telix initiatives: Sponsored symposium on personalised diagnostics in urological cancers: the promise of nuclear medicine; Phase III ProstACT GLOBAL study of TLX591 investigational prostate cancer therapy; Artificial intelligence (AI) Segmentation and primary characterisation of prostate cancer lesions using models trained on 68Ga-PSMA-11 image datasets; Nobody ....

North Melbourne , Al Qahirah , United Kingdom , United States , Region Flamande , Kyahn Williamson , Eduards Mamlins , Karolien Goffin , Yehia Omar , Fuad Novruzov , Clement Bailly , Macarena Rodriguez Fraile , Neel Patel , Colin Hayward , Stefano Fanti , Sanjiv Sam Gambhir Young , Simone Kleinendorst , Laszlo Papp , Misr Radiology Center , European Association Of Nuclear Medicine , Australian Securities Exchange , University Hospital Leuven , European Union , University Hospital Duesseldorf , Department Of Nuclear Medicine , Telix Pharmaceuticals ,